354 Results

People

  1. Chaganti
    Chaganti
  2. Jhanwar
    Jhanwar
  3. Ladanyi
    Ladanyi
  4. Tallman
    Tallman
  5. Levine
    Levine
  6. Giralt
    Giralt
  7. Rao
    Rao
  8. Usmani
    Usmani
  9. Zhang
    Zhang
  10. Filippa
    Filippa

Groups

  1. Department of Medicine (166)
  2. Center for Hematologic Malignancies (148)
  3. Hematologic Malignancies, Division of (146)
  4. Adult Leukemia (81)
  5. GSK Faculty (81)
  6. Department of Pathology and Laboratory Medicine (67)
  7. Tow Center for Developmental Oncology (TCDO) (56)
  8. Sloan Kettering Institute Faculty (50)
  9. Human Oncology and Pathogenesis Program (46)
  10. Survivorship Research (40)
  1. "cytogenetics"
Formats
  1. Journal Article (316)
  2. Review (11)
  3. Research Letter (10)
  4. Editorial (7)
  5. Correspondence (3)
  6. Guidelines (3)
  7. Meeting Abstract (2)
  8. Book Section (1)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (166)
  2. Center for Hematologic Malignancies (148)
  3. Hematologic Malignancies, Division of (146)
  4. Adult Leukemia (81)
  5. GSK Faculty (81)
  6. Department of Pathology and Laboratory Medicine (67)

More Groups

People
  1. Raju Chaganti (40)
  2. Suresh Jhanwar (36)
  3. Martin Tallman (33)
  4. Marc Ladanyi (21)
  5. Ross Levine (19)
  6. Sergio Giralt (14)

More People

Years
  1. 2025 (7)
  2. 2024 (27)
  3. 2023 (11)
  4. 2022 (9)
  5. 2021 (9)
  6. 2020 (12)

More Years

Publications
  1. Blood (35)
  2. Genes Chromosomes and Cancer (17)
  3. Leukemia Research (13)
  4. American Journal of Surgical Pathology (12)
  5. Journal of the National Comprehensive Cancer Network (12)
  6. Journal of Clinical Oncology (11)

More Publications

Publishers
  1. Elsevier Inc. (53)
  2. American Society of Hematology (44)
  3. Nature Publishing Group (28)
  4. Elsevier Science, Inc. (23)
  5. Wiley Blackwell (20)
  6. Wiley Periodicals, Inc (19)

More Publishers

Results (354)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of rare structural variant events in newly diagnosed multiple myeloma
    Journal Article

    Chojnacka, M.; Diamond, B.; Ziccheddu, B.; Rustad, E.; Maclachlan, K.; Papadimitriou, M.; Boyle, E. M.; Blaney, P.; Usmani, S.; Morgan, G.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Research Letter

    Badar, T.; Nanaa, A.; Atallah, E.; Shallis, R. M.; Guilherme, S. D. C. C.; Goldberg, A. D.; Saliba, A. N.; Patel, A.; Bewersdorf, J. P.; DuVall, A. S.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia
    Journal Article

    Cancio, M.; Troullioud Lucas, A. G.; Bierings, M.; Klein, E.; de Witte, M. A.; Smiers, F. J.; Bresters, D.; Boelens, J. J.; Smetsers, S. E.
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: Updated recommendations by the EBMT/ELN International Working Group
    Review

    Kröger, N.; Bacigalupo, A.; Barbui, T.; Ditschkowski, M.; Gagelmann, N.; Griesshammer, M.; Gupta, V.; Hamad, N.; Harrison, C.; Hernandez-Boluda, J. C.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Few and far between: Clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas
    Review

    Stuver, R.; Epstein-Peterson, Z. D.; Horwitz, S. M.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Cytogenetics and molecular genetics of myelodysplastic neoplasms
    Review

    Ning, Y.; Zhang, Y.; Kallen, M. A.; Emadi, A.; Baer, M. R.
    Best Practice and Research: Clinical Haematology (2023)

    Fulltext@MSK | Save
  • Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers
    Journal Article

    Setton, J.; Hadi, K.; Choo, Z. N.; Kuchin, K. S.; Tian, H.; Da Cruz Paula, A.; Rosiene, J.; Selenica, P.; Behr, J.; Yao, X.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Journal Article

    Badar, T.; Atallah, E.; Shallis, R.; Saliba, A. N.; Patel, A.; Bewersdorf, J. P.; Grenet, J.; Stahl, M.; Duvall, A.; Burkart, M.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: A phase 1, dose-finding and expansion study
    Journal Article

    Garcia-Manero, G.; Goldberg, A. D.; Winer, E. S.; Altman, J. K.; Fathi, A. T.; Odenike, O.; Roboz, G. J.; Sweet, K.; Miller, C.; Wennborg, A.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Comparative efficacy of teclistamab versus physician's choice of therapy in the long-term follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS clinical trials in patients with triple-class exposed relapsed or refractory multiple myeloma
    Journal Article

    Mateos, M. V.; Chari, A.; Usmani, S. Z.; Goldschmidt, H.; Weisel, K.; Qi, K.; Londhe, A.; Nair, S.; Lin, X.; Pei, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save